Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes

Ronald M. Salomon, John S. Kennedy, Benjamin W. Johnson, Jennifer Urbano Blackford, Dennis E. Schmidt, Joseph Kwentus, Harry E. Gwirtsman, John F. Gouda, Richard G. Shiavi

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Unipolar and bipolar depressions show abnormal behavioral manifestations of ultradian (less than 24 h) rhythms, but abnormal rhythms of the central neurotransmitters thought to be important for depression pathophysiology (eg dopamine (DA) and serotonin (5-HT)) have not been shown in this time frame. Since antidepressant treatments normalize disrupted rhythms in depression (eg rapid-eye-movement sleep and hormonal rhythms), we hypothesized that depression-related changes in ultradian oscillations of DA and 5-HT might be revealed during antidepressant treatment. Cerebrospinal fluid (CSF) samples collected q10 min for 24 h in 13 patients experiencing major depressive episodes (MDE) before and after treatment for 5 weeks with sertraline or bupropion were assayed for levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA), and their ratio was calculated. Data were analyzed in the frequency domain using Fourier transforms and multivariate permutation testing. Antidepressant treatments were associated with decreased variance for 5-HIAA, increased variance for HVA, and markedly increased variance for the HVA:5-HIAA ratio (p < 0.05, p < 0.02, and p < 0.003, respectively). With treatment, the correlations between 5-HIAA and HVA weakened (p = 0.06). Power spectral density (PSD - the Fourier magnitude squared) of the 5-HIAA signals at periods of 1.75 and 3.7 h (both p < 0.05) decreased, while circadian cycling of HVA levels (p < 0.05) and of the ratio (p < 0.005) increased after treatment. The PSD of the full-length HVA:5-HIAA ratio series after treatment increased in rapid variability (20-103 min periods, p < 0.05). Spectrographic windowing demonstrated a focal span of enhanced HVA:5-HIAA ratio variability following antidepressant treatment, in an approximately 84-min period through the evening (p < 0.05). Periodic neurotransmitter relationships in depressed patients were altered by treatment in this analysis of a small data set. This may represent a baseline abnormality in the regulation of periodic functions involved in the depression pathophysiology, but it could also be due to an unrelated antidepressant effect. Further studies including comparisons with healthy subject data are in progress.

Original languageEnglish (US)
Pages (from-to)2082-2091
Number of pages10
JournalNeuropsychopharmacology
Volume30
Issue number11
DOIs
StatePublished - Nov 2005
Externally publishedYes

Keywords

  • 5-hydroxyindoleacetic acid (5-HIAA)
  • Biological rhythms
  • Depression
  • Homovanillic acid (HVA)
  • Multivariate permutation test
  • Time series

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes'. Together they form a unique fingerprint.

Cite this